MAR 18, 2016 1:19 PM PDT

New Component of Macrophage Metabolism Discovered

WRITTEN BY: Kara Marker
How are macrophage immune cells activated during an inflammatory response when pathogens invade? Scientists thought they knew this and more, but recent studies from the Luxembourg Centre for Systems Biomedicine (LCSB) at the University of Luxembourg discovered something different.
 
Upon activation, macrophage metabolism pathways lead to the production of antimicrobial substances and fatty acids which deliver important resources during an infection. With their new discoveries into how these pathways work, the researchers, who study was recently published in the Journal of Biological Chemistry may have also developed a new approach for treating chronic inflammatory diseases.
 
Macrophages are key immune cells of the innate immune system, the system of first-responder cells that react when pathogens invade. Macrophages are activated upon recognition of pathogen antigens or contact with cytokines, and their activation reprograms macrophage metabolism.
 
"A hungry macrophage"

Hif1 is important protein for this very metabolism reprogramming, but it is also known to exist in cases of cancer. Cancer cells exist in an oxygen-poor tumor environment, which stabilizes Hif1 and prevents the tumor from being degraded. This causes less pyruvate to be introduced into the citric acid cycle, which is vital for producing energy for the body to perform multiple functions.
 
Apparently, Hif1 is also found in its stabilized forms in activate macrophages even though it is not an oxygen-poor environment. Previously, scientists thought this meant the metabolic pathways stemming from macrophage activation were similar to cancer cell pathways. However, the recent study from the University of Luxembourg instead showed that macrophages are able to facilitate pyruvate into the citric acid cycle despite Hif1 stabilization, allowing energy production to continue like normal.
 
"Conversion of pyruvate is a pivotal step in the inflammatory event, and thus presents a starting point for developing anti-inflammatory therapies," said Karsten Hiller, PhD. "This would be helpful for diseases associated with an excessive inflammatory response, such as allergies or septic shock."
 
Because of their ability, macrophages can also produce an “endogenous antibiotic” called itaconic acid and fatty acids needed for macrophage growth.
 
 
Source: University of Luxembourg
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
FEB 13, 2020
Cancer
FEB 13, 2020
Can Ebola help treat glioblastomas?
You might want to sit down for this. New research published in the Journal of Virology has named a surprising new a ...
MAR 31, 2020
Health & Medicine
MAR 31, 2020
20 Facts About the Placenta - A Lifeline Between a Mother and Her Baby
The placenta is the lifeline that connects the mother and her baby. It is a multi-functiona organ that is responsible fo ...
MAR 28, 2020
Drug Discovery & Development
MAR 28, 2020
Could the Blood of Coronavirus Survivors Save Lives?
As the search for a treatment for coronavirus continues, a perhaps obscure-sounding candidate has begun to make headline ...
APR 07, 2020
Immunology
APR 07, 2020
Too Much Salt Is Bad for the Immune System
Excessive salt intake is associated with health consequences for more than just cardiovascular status; the immune system ...
APR 21, 2020
Health & Medicine
APR 21, 2020
How to Read COVID-19 News (Without Going Crazy)
  It can feel like COVID-19 news is consuming the country, and taking all the toilet paper and N95-masks with it. N ...
APR 20, 2020
Drug Discovery & Development
APR 20, 2020
First Successful Vaccine for Middle-East Respiratory Syndrome
Researchers have successfully completed the first-in-human clinical trial for a vaccine against MERS (Middle East Respir ...
Loading Comments...